- Home
- ACRV vs AEVA Comparison
ACRV vs AEVA Comparison
Compare ACRV & AEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACRV
- AEVA
- Stock Information
- Founded
- ACRV 2018
- AEVA 2019
- Country
- ACRV United States
- AEVA United States
- Employees
- ACRV 61
- AEVA N/A
- Industry
- ACRV Medicinal Chemicals and Botanical Products
- AEVA Auto Parts:O.E.M.
- Sector
- ACRV Health Care
- AEVA Consumer Discretionary
- Exchange
- ACRV Nasdaq
- AEVA Nasdaq
- Market Cap
- ACRV 73.5M
- AEVA 192.9M
- IPO Year
- ACRV 2022
- AEVA N/A
- Fundamental
- Price
- ACRV $2.24
- AEVA $6.71
- Analyst Decision
- ACRV Strong Buy
- AEVA Buy
- Analyst Count
- ACRV 6
- AEVA 5
- Target Price
- ACRV $21.80
- AEVA $5.81
- AVG Volume (30 Days)
- ACRV 162.1K
- AEVA 1.2M
- Earning Date
- ACRV 05-13-2025
- AEVA 03-19-2025
- Dividend Yield
- ACRV N/A
- AEVA N/A
- EPS Growth
- ACRV N/A
- AEVA N/A
- EPS
- ACRV N/A
- AEVA N/A
- Revenue
- ACRV N/A
- AEVA $9,065,000.00
- Revenue This Year
- ACRV N/A
- AEVA $62.97
- Revenue Next Year
- ACRV N/A
- AEVA $227.44
- P/E Ratio
- ACRV N/A
- AEVA N/A
- Revenue Growth
- ACRV N/A
- AEVA 110.23
- 52 Week Low
- ACRV $2.14
- AEVA $2.20
- 52 Week High
- ACRV $11.90
- AEVA $7.07
- Technical
- Relative Strength Index (RSI)
- ACRV 22.41
- AEVA 83.11
- Support Level
- ACRV $5.00
- AEVA $2.64
- Resistance Level
- ACRV $5.65
- AEVA $4.31
- Average True Range (ATR)
- ACRV 0.44
- AEVA 0.43
- MACD
- ACRV -0.33
- AEVA 0.44
- Stochastic Oscillator
- ACRV 2.85
- AEVA 92.09
About ACRV Acrivon Therapeutics Inc.
Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's pipeline includes the Phase 2 lead program, ACR-368, referred to as prexasertib, a targeted oncology asset, as well as preclinical stage pipeline programs targeting critical nodes in the DNA Damage Response and cell cycle regulation pathways, including WEE1, a protein kinase, and PKMYT1, a closely related protein serine/threonine kinase.
About AEVA Aeva Technologies Inc.
Aeva Technologies Inc through its Frequency Modulated Continuous Wave (FMCW) sensing technology, designs a 4D LiDAR-on-chip that, along with its proprietary software applications, has the potential to enable the adoption of LiDAR across broad applications from automated driving to consumer electronics, consumer health, industrial automation, and security application. The company operates in North America, EMEA, and Asia. The company derives the majority of its revenue from North America.